Advertisements

Stocking Stuffers

 

BriaCell Therapeutics Corp. (BCT:CA) Stock Quote

Detailed Quote for BriaCell Therapeutics Corp. (BCT:CA)
$ 0.05 0.00 (0.00%) Volume: 140k 12:03 PM EST Dec 12, 2019
Today 5d 1m 3m 1y more
Last Price
0.05
Change $
Change %
Tick
  
Bid
0.045
Bid Size
140,000
Ask
0.05
Ask Size
57,000
Open
0.055
High
0.055
Low
0.05
Prev Close
0.05
Last Trade
12:03
Volume
140k
52 Wk Hi
0.150000005
52 Wk Low
0.035
Market Cap
10.83m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
216,589,090
EPS (TTM)
-0.039999999
PE Ratio
N/A
Exchange
TSXV
News and Media for BriaCell Therapeutics Corp. (BCT:CA)
Sector News | Topic News
News for BriaCell Therapeutics Corp. (BCT:CA)
Tue, Nov 12, 2019
6:30 AM BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium\u00AE December 12th and 13th - GlobeNewswire
Thu, Oct 24, 2019
6:30 AM BriaCell Announces Voting Results of the Special Meeting of Shareholders - GlobeNewswire
Tue, Oct 15, 2019
5:33 PM BriaCell Announces Closing of Non-Brokered Private Placement of $568,444 - GlobeNewswire
Tue, Oct 08, 2019
7:00 PM BriaCell Therapeutics Corp. to File Amendment to Management Information Circular - GlobeNewswire
Mon, Oct 07, 2019
6:31 AM BriaCell CEO: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments - Investing News Network
6:30 AM BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMT(TM) in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer - GlobeNewswire
Tue, Oct 01, 2019
7:00 PM BriaCell Therapeutics Corp. to Clarify Record Date - GlobeNewswire
6:30 AM Note from Chairman of BriaCell Therapeutics - October is Breast Cancer Awareness Month - GlobeNewswire
Wed, Sep 25, 2019
6:30 AM BriaCell Appoints Immunology Expert, Dr. Cara L. Haymaker, to Scientific Advisory Board; BriaCell CEO to Lead Special 'Targeted Immunotherapy' Issue in Prestigious Journals - GlobeNewswire
Fri, Sep 20, 2019
11:03 AM BriaCell Announces Private Placement of up to $600,000 - GlobeNewswire
Thu, Sep 19, 2019
11:29 AM IIROC Trading Resumption - BCT - Canada Newswire
10:00 AM BriaCell Announces Public Disclosure: Remarkable Responder in Combination Study of Lead Candidate with KEYTRUDA\u00AE - GlobeNewswire
9:12 AM IIROC Trading Halt - BCT - Canada Newswire
Mon, Sep 16, 2019
6:30 AM BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia - GlobeNewswire
Tue, Sep 10, 2019
8:55 AM Bondarenko Acquires 16.2% Beneficial Ownership of BriaCell Therapeutics Corp. - GlobeNewswire
Mon, Sep 09, 2019
5:33 PM BriaCell Announces Closing of Upsized Non-Brokered Private Placement of $846,301.49 - GlobeNewswire
Tue, Aug 27, 2019
6:30 AM BriaCell Announces Participation at the 21st Annual Global Investment Conference in New York City September 8-10, 2019 - GlobeNewswire
Mon, Aug 12, 2019
6:30 AM BriaCell Appoints Richard J. Berman to Board of Directors - GlobeNewswire
Tue, Jul 23, 2019
6:30 AM BriaCell Announces $350,000 Equity Investment by Board of Directors - GlobeNewswire
Tue, May 28, 2019
6:30 AM BriaCell's Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewswire
More News for BCT:CA >>

Tags for BriaCell Therapeutics Corp.

Research stocks or mutual funds related to BriaCell Therapeutics Corp. by keywords or tags. Find companies that have a similar focus to BCT:CA. The keywords below have been associated to BCT:CA by either user submission or electronic means.